In vivo experiments demonstrated that IL-24 intervention not only improved insulin resistance and glucose intolerance but also significantly reduced hepatic steatosis, accompanied by a restoration of serum metabolic parameters (i.e., blood glucose, lipids, uric acid). The gene discussed is IL24; the disease is fatty liver disease.